Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type.
Front Oncol. 2023 Jan 16;12:1082062. doi: 10.3389/fonc.2022.1082062. eCollection 2022.
Front Oncol. 2023.
PMID: 36727064
Free PMC article.
Review.
IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups.
Rudà R, Bruno F, Ius T, Silvani A, Minniti G, Pace A, Lombardi G, Bertero L, Pizzolitto S, Pollo B, Conti Nibali M, Pellerino A, Migliore E, Skrap M, Bello L, Soffietti R.
Rudà R, et al.
Neuro Oncol. 2022 May 4;24(5):809-820. doi: 10.1093/neuonc/noab239.
Neuro Oncol. 2022.
PMID: 34651653
Free PMC article.
Item in Clipboard
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016.
Rudà R, Pellerino A, Pace A, Carapella CM, Dealis C, Caroli M, Faedi M, Bello L, Migliore E, Marchese G, Bertero L, Cassoni P, Soffietti R.
Rudà R, et al.
J Neurooncol. 2019 Dec;145(3):593. doi: 10.1007/s11060-019-03331-8.
J Neurooncol. 2019.
PMID: 31691059
Item in Clipboard
Cite
Cite